UGDH and neoplasm: Together, these results indicate that, despite being under an anti-tumoral treatment and with less availability of the UGDH enzyme, tumor cells activate several mechanisms directly related to tumor progression and drug resistance, despite the cells reducing its glucuronidation and/or elimination.